Watch this webinar to hear from Dr. Derek Exner, Medical Director, the Integrated Management Platform to Accelerate Clinical Trials (IMPACT), as he discusses the resources that the IMPACT program provides for new ventures in the life sciences or biomedical industries that seek to commercialize their health-related inventions, conduct clinical trials, and secure regulatory approval.
- Learn about the IMPACT clinical trial accelerator program and how it assists new ventures in navigating the complex process of planning for, setting up, and executing a clinical trial for a new medical device or drug.
- Learn about why conducting clinical trials for the purpose of commercializing a new medical device or drug is necessary.
- Learn how the University of Calgary environment is one of the best and most supportive in Canada for new ventures to conduct their clinical trials in.
- Demo IMPACT’s novel regulatory management platform (TRACR) designed to automate regulatory submissions and adverse event reporting
About Dr. Derek Exner, Medical Director, IMPACT
Dr. Exner is Canada Research Chair in Cardiovascular Clinical Trials, a Professor and an Associate Dean at the University of Calgary. Derek founded the IMPACT clinical trials program for medical ventures. He is a practicing cardiologist, heart rhythm specialist, and clinical trials expert. His clinical work and research focus on Cardiac Implantable Electrical Device (CIED) therapy. He has authored or co-authored over 300 articles, book chapters, and abstracts and has chaired and participated on multiple Guidelines Committees. Derek is actively engaged in several medical technology ventures, serving as the Chief Medical Officer of HelpWear Inc. and acting as an advisor to several other companies.
*This webinar is a part of the Innovate Calgary and Life Sciences Innovation Hub Webinar Series